Aurobindo Pharma Ltd 2021 Annual Report with Sustainability Disclosures
Company: Aurobindo Pharma Ltd
Sector: Manufacturing
Country: India
Year: 2021
Type: Annual Report with Sustainability Disclosures
Pages: 300
The report presents FY21 consolidated revenues of INR 247,746.2 million and highlights a 52,725 tCO2e reduction in carbon emissions. The company also generated approximately 40,000 MWh of solar electricity and reported 9.2 lakh CSR beneficiaries in FY21.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.